Table 2.
Vancomycin use, evaluation of 58 patients during one year in a hematology oncology ward.
| Appropriate vancomycin initiation,continuation | |
|---|---|
| In febrile neutropenia1 n (%) | 42 from 51 (68.63%) |
| In nonfebrile neutropenia 1 n (%) | 5 from 7 (71.43%) |
| Length of therapy 1 n (%) | 29 (50%) |
| Other appropriate vancomycin utilization | |
| Vancomycin dilution n (%) | 58 (100%) |
| Initial dosage n (%) | 55 (94.8%) |
| Dosing interval n (%) | 56 (96.5%) |
| Maintenance dosage n (%) | 29 (50%) |
| Rate of infusion n (%) | 58 (100%) |
| Correcting dosage based on creatinin clearance 3 n (%) | 10 (17.23%) |
| Appropriate therapeutic level 2 n (%) | 25 (43.1%) |
1. Compare with IDSA 2010 guideline.
2. Minimum trough serum concentration should be above 10 mg/L and in complicated nfections(bacterimia, endocarditis, osteomyelitis, meningitis and hospital acquired pneumonia). trough serum concentrations of 15-20 mg/L are recommended.
3. Renal function calculated based on Cockroft-Gault equation.